Automated Ionic® Cells to Pure DNA Low Input Kit consistently recovers up to twice the amount of high-quality nucleic acid from as few as 10 cultured or sorted cells
Purigen Biosystems, Inc., a leading provider of next-generation technologies for extracting and purifying nucleic acids from biological samples, today announced the launch of the Ionic® Cells to Pure DNA Low Input Kit for researchers working with limited biological samples. The simplified and automated 60-minute workflow delivers high-quality DNA for the rapid investigation of genetic abnormalities or examination of disease treatment effects.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201013005344/en/
The Ionic Cells to Pure DNA Low Input Kit from Purigen Biosystems (Photo: Business Wire)
The Ionic Cells to Pure DNA Low Input Kit offers consistent recovery of DNA with yields near the theoretical maximum for as many as 100,000 down to as few as 10 cultured
Agreement includes $10M investment to be used for growth initiatives
SAN FRANCISCO, Sept. 28, 2020 /PRNewswire/ — Molekule, the company reinventing air purification, today announced that it closed a partnership agreement with Sourcenext, (listed on the first section of the Tokyo Stock Exchange, code: 4344), a market maker for brands in Japan including software, hardware, and IoT products. The agreement signals the next phase of growth for Molekule, which includes global expansion. In a commitment to Molekule’s innovation, Sourcenext has also invested $10 million into the company. The funds will be used for growth initiatives as the company prepares to meet strong global demand for an air purification solution that destroys airborne pollutants, including viruses and chemicals.
“Molekule’s breakthrough and patented PECO technology is unique in the marketplace, offering a new solution that both captures and destroys air pollutants,” said Nori Matsuda, Founder and